Pierre Devaux

Pharmacist – CEO Theraxel-Point Forty Five

Theraxel-Point Forty Five is a Company specialized in consulting, technical assistance, regulatory audits and training around the control of the chemical risk, Microbiological, particulate and pyrogenic for non-sterile, sterile and biotechnological pharmaceutical industries as well as related industries such as cosmetic industries.

Pierre Devaux is a specialist in Part I, Annex 1 and Annex 15 of the European GMP, ICHQ9 and FDA guidelines on aseptic and validation processes and ISO22716

He has the following experience:

• 6 years as responsible for the quality control laboratories and the management of the environmental monitoring of the ZAC of the Excelvision Fareva French site;
• 5 years as Qualified Person/Quality Director of the ACM Pharma French laboratory, while carrying out consulting missions via the company UPS Consultants.
• Head within the French Association A3P of the Common Interest Group on GMP Annex 15 and Cleaning Validation.
• Speaker for ISPE Nordic and Trainer for A3P Services as well as for Key2Compliance®.